DMYD-BDiamyd Medical AB (publ)
1.002SEK-1.76%Mkt Cap: 14.85M $P/E: —3d ago
Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatm…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap14.85M $
Enterprise Value-17.98M $
Revenue (TTM)41.32K $
Gross Profit-354.39K $
Net Income (TTM)-16.24M $
Revenue/Share0.0003 USD
Last Price1.002 SEK
Fiscal Year EndAug 2025
MR QuarterMay 2026
Employees44
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.67
EV/Revenue-435.23
P/S365.22
P/B0.61
EPS (TTM)-2.00
EPS (Forward)—
52W Range
0.89601% of range17.88
52W High17.88 SEK
52W Low0.8960 SEK
Profitability
Gross Margin0.00%
Oper. Margin-181711.43%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-60.64%
ROA-44.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.26M $
CapEx (TTM)—
FCF Margin-39123.29%
FCF Yield-108.83%
Net Debt-33.11M $
Net Debt/EBITDA1.23
Balance Sheet
Debt/Equity—
Current Ratio15.50
Quick Ratio15.41
Book Value/Sh1.674 SEK
Cash/Share2.233 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.151.48M
Float135.38M
Insiders14.25%
Institutions23.41%
Technical
SMA 501.064 (-5.8%)
SMA 2006.875 (-85.4%)
Beta2.29
S&P 52W Chg18.16%
Avg Vol (30d)391.73K
Avg Vol (10d)445.90K
Technical Indicators
RSI (14)38.1
MACD-0.0240
MACD Signal-0.0289
MACD Hist.+0.0049
BB Upper1.050 SEK
BB Middle1.026 SEK
BB Lower1.003 SEK
BB Width4.56%
ATR (14)0.0472 SEK
Vol Ratio (20d)1.26x